Labcorp Holdings (LH) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Labcorp Holdings Revenue Highlights

Latest Revenue (Y)

$13.95B

Latest Revenue (Q)

$3.54B

Main Segment (Y)

LabCorp Diagnostics

Main Geography (Y)

North America

Labcorp Holdings Revenue by Period

Labcorp Holdings Revenue by Year

Date	Revenue	Change
2025-12-31	$13.95B	7.25%
2024-12-31	$13.01B	6.97%
2023-12-31	$12.16B	2.51%
2022-12-31	$11.86B	-9.68%
2021-12-31	$13.14B	-6.03%
2020-12-31	$13.98B	20.98%
2019-12-31	$11.55B	1.95%
2018-12-31	$11.33B	8.54%
2017-12-31	$10.44B	8.29%
2016-12-31	$9.64B	11.08%
2015-12-31	$8.68B	44.39%
2014-12-31	$6.01B	3.50%
2013-12-31	$5.81B	2.41%
2012-12-31	$5.67B	2.33%
2011-12-31	$5.54B	10.76%
2010-12-31	$5.00B	6.59%
2009-12-31	$4.69B	4.21%
2008-12-31	$4.51B	10.74%
2007-12-31	$4.07B	13.30%
2006-12-31	$3.59B	7.91%
2005-12-31	$3.33B	7.87%
2004-12-31	$3.08B	4.95%
2003-12-31	$2.94B	17.21%
2002-12-31	$2.51B	14.00%
2001-12-31	$2.20B	14.61%
2000-12-31	$1.92B	12.99%
1999-12-31	$1.70B	5.34%
1998-12-31	$1.61B	6.16%
1997-12-31	$1.52B	-5.52%
1996-12-31	$1.61B	12.27%
1995-12-31	$1.43B	64.13%
1994-12-31	$872.50M	14.73%
1993-12-31	$760.50M	-

Labcorp Holdings generated $13.95B in revenue during NA 2025, up 7.25% compared to the previous quarter, and up 99.81% compared to the same period a year ago.

Labcorp Holdings Revenue by Quarter

Date	Revenue	Change
2026-03-31	$3.54B	0.62%
2025-12-31	$3.52B	-1.34%
2025-09-30	$3.56B	1.03%
2025-06-30	$3.53B	5.45%
2025-03-31	$3.35B	0.47%
2024-12-31	$3.33B	1.44%
2024-09-30	$3.28B	1.90%
2024-06-30	$3.22B	1.39%
2024-03-31	$3.18B	4.72%
2023-12-31	$3.03B	-0.77%
2023-09-30	$3.06B	0.76%
2023-06-30	$3.03B	-0.13%
2023-03-31	$3.04B	-17.32%
2022-12-31	$3.67B	28.16%
2022-09-30	$2.87B	-1.92%
2022-06-30	$2.92B	-25.04%
2022-03-31	$3.90B	-3.86%
2021-12-31	$4.06B	-0.16%
2021-09-30	$4.06B	5.78%
2021-06-30	$3.84B	-7.71%
2021-03-31	$4.16B	-7.31%
2020-12-31	$4.49B	15.24%
2020-09-30	$3.90B	40.71%
2020-06-30	$2.77B	-1.95%
2020-03-31	$2.82B	-4.39%
2019-12-31	$2.95B	0.85%
2019-09-30	$2.93B	1.62%
2019-06-30	$2.88B	3.24%
2019-03-31	$2.79B	0.13%
2018-12-31	$2.79B	-1.55%
2018-09-30	$2.83B	-1.22%
2018-06-30	$2.87B	0.63%
2018-03-31	$2.85B	1.86%
2017-12-31	$2.80B	5.31%
2017-09-30	$2.66B	4.42%
2017-06-30	$2.54B	3.92%
2017-03-31	$2.45B	0.77%
2016-12-31	$2.43B	0.57%
2016-09-30	$2.41B	-0.66%
2016-06-30	$2.43B	2.65%
2016-03-31	$2.37B	2.19%
2015-09-30	$2.32B	2.12%
2015-06-30	$2.27B	26.54%
2015-03-31	$1.79B	18.54%
2014-12-31	$1.51B	-2.52%
2014-09-30	$1.55B	2.33%
2014-06-30	$1.52B	5.99%
2014-03-31	$1.43B	-0.44%
2013-12-31	$1.44B	-1.72%
2013-09-30	$1.46B	-0.41%
2013-06-30	$1.47B	1.89%
2013-03-31	$1.44B	2.53%
2012-12-31	$1.41B	-0.99%
2012-09-30	$1.42B	-0.28%
2012-06-30	$1.42B	0.01%
2012-03-31	$1.42B	4.19%
2011-12-31	$1.37B	-2.73%
2011-09-30	$1.40B	0.09%
2011-06-30	$1.40B	2.55%
2011-03-31	$1.37B	5.64%
2010-12-31	$1.30B	1.48%
2010-09-30	$1.28B	3.08%
2010-06-30	$1.24B	3.75%
2010-03-31	$1.19B	2.45%
2009-12-31	$1.17B	-1.69%
2009-09-30	$1.19B	-0.31%
2009-06-30	$1.19B	2.86%
2009-03-31	$1.16B	3.27%
2008-12-31	$1.12B	-1.41%
2008-09-30	$1.14B	-1.11%
2008-06-30	$1.15B	4.04%
2008-03-31	$1.10B	9.68%
2007-12-31	$1.01B	-

Labcorp Holdings generated $3.54B in revenue during Q1 2026, up 0.62% compared to the previous quarter, and up 106.25% compared to the same period a year ago.

Labcorp Holdings Revenue Breakdown

Labcorp Holdings Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 22	Dec 21	Dec 19
LabCorp Diagnostics	$10.88B	$10.14B	$7.00B	-	-
Diagnostics	-	-	$9.20B	$20.73B	-
Drug Development	-	-	$5.71B	$11.69B	-
Covance Drug Development	-	-	-	-	$4.58B

Labcorp Holdings's latest annual revenue breakdown by segment (product or service), as of Dec 25: LabCorp Diagnostics (100.00%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
LabCorp Diagnostics	$2.76B	$2.73B	$2.77B	$2.75B	$2.63B	$2.59B	$2.55B	$2.52B	$2.48B	-	-	-
Biopharma Laboratory Services	$780.60M	-	-	-	-	-	-	-	-	-	-	-
Covance Drug Development	-	-	-	-	-	-	$737.70M	$707.00M	$710.90M	-	-	-
Diagnostics	-	-	-	-	-	-	-	-	$2.48B	$9.42B	$2.34B	$2.34B
Drug Development	-	-	-	-	-	-	-	-	$710.90M	$2.77B	$719.10M	$699.00M

Labcorp Holdings's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: LabCorp Diagnostics (77.97%), and Biopharma Laboratory Services (22.03%).

Labcorp Holdings Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 21	Dec 20	Dec 19	Dec 18
North America	$13.09B	$11.53B	-	-
Europe	$2.05B	$1.51B	-	-
Other countries	$976.40M	$941.00M	$1.20B	$1.18B

Labcorp Holdings's latest annual revenue breakdown by geography, as of Dec 21: North America (81.22%), Europe (12.72%), and Other countries (6.06%).

Quarterly Revenue by Country

Country	Mar 26	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Dec 21
UNITED STATES	$2.91B	$2.97B	$2.93B	$2.81B	$2.74B	$2.70B	$2.65B	$2.55B	$2.54B	-
Other countries	-	-	-	-	-	-	-	-	-	$976.40M
Europe	-	-	-	-	-	-	-	-	-	$2.05B
North America	-	-	-	-	-	-	-	-	-	$13.09B

Labcorp Holdings's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (100.00%).

Labcorp Holdings Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LH	Labcorp	$13.95B	$3.54B
DGX	Quest Diagnostics	$11.04B	$2.90B
BIIB	Biogen	$9.81B	$2.48B
ZBH	Zimmer Biomet	$8.23B	$2.09B
STE	STERIS	$5.94B	$1.50B
INCY	Incyte	$5.14B	$1.27B
DXCM	DexCom	$4.66B	$1.19B
ILMN	Illumina	$4.34B	$1.08B
UTHR	United Therapeutics	$3.18B	$799.50M
WAT	Waters	$3.17B	$1.27B
WST	West Pharmaceutical Services	$3.07B	$844.90M

LH Revenue FAQ

What is Labcorp Holdings’s yearly revenue?

Labcorp Holdings's yearly revenue for 2025 was $13.95B, representing an increase of 7.25% compared to 2024. The company's yearly revenue for 2024 was $13.01B, representing an increase of 6.97% compared to 2023. LH's yearly revenue for 2023 was $12.16B, representing an increase of 2.51% compared to 2022.

What is Labcorp Holdings’s quarterly revenue?

Labcorp Holdings's quarterly revenue for Q1 2026 was $3.54B, a 0.62% increase from the previous quarter (Q4 2025), and a 5.75% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $3.52B, a -1.34% decrease from the previous quarter (Q3 2025), and a 5.60% increase year-over-year (Q4 2024). LH's quarterly revenue for Q3 2025 was $3.56B, a 1.03% increase from the previous quarter (Q2 2025), and a 8.58% increase year-over-year (Q3 2024).

What is Labcorp Holdings’s revenue growth rate?

Labcorp Holdings's revenue growth rate for the last 3 years (2023-2025) was 14.72%, and for the last 5 years (2021-2025) was 6.21%.

What are Labcorp Holdings’s revenue streams?

Labcorp Holdings's revenue streams in c 25 are LabCorp Diagnostics

What is Labcorp Holdings’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Labcorp Holdings was LabCorp Diagnostics. This segment made a revenue of $10.88B, representing 100.00% of the company's total revenue.